Series B momentum The Protein Brewery recently secured significant Series B funding and extensions totaling around $85 million, signaling strong investor confidence and capacity to scale. This presents an opportunity to approach strategic partners and co-development opportunities with better fundraising credibility and expanded production capabilities.

Scale-ready production Funding is explicitly allocated to scale production capacity for Fermotein and to amplify active nutrition sales. Sales efforts can target major food and beverage brands seeking scalable, sustainable protein ingredients for nutrition bars, RTMs, and dairy alternatives.

Sustainability moat Fermotein is produced via a zero-waste fungal fermentation process converting sugar-rich streams into protein, appealing to sustainability-focused customers and brands pursuing green ingredient portfolios, carbon footprint reduction, and clean-label positioning.

EU and health grants Recent EU LIFE and EIT Food grants validate external funding and accelerate commercialization in dairy alternatives and health/wellness products. This creates partnership openings with EU-funded programs, co-development ventures, and grant-aligned marketing campaigns.

Niche market focus Current revenue is under $1M with funding totaling $64M, and a small team. The company targets active nutrition and longevity, providing a niche entry point for partnerships with wellness brands, fortified foods, and sports nutrition players seeking innovative mycoprotein ingredients.